Latest Renal News

Natural Treatment and Maintenance of Prostate Enlargement with New Thermobalancing Therapy Improves Men’s Well-being in Safety States Fine TreatmentFine Treatment recommends new Thermobalancing Therapy as successful natural solution for benign prostatic hyperplasia that is also the most cost-effective prostate treatment on the market. While long-term medication courses and BPH surgeries may cost thousands of dollars, the price of Dr. Allen’s Device for Prostate Treatment under $150 makes it widely affordable. London, UK (PRWEB) May 26, 2012...

ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule Inhibitor of C5aR, at the 49th European Renal Association - European Dialysis and Transplant Association CongressMOUNTAIN VIEW, Calif., May 26, 2012 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI), today announced the presentation of results from the Company's development program for CCX168, an investigational orally administered inhibitor of the complement anaphylatoxin receptor known as C5aR. CCX168 is currently in a multinational, randomized, double-blind, placebo-controlled Phase II clinical trial...

As Obesity Rates Rise, Cases of Kidney Stones Double: StudyFRIDAY, May 25 -- The number of Americans suffering from kidney stones has almost doubled since 1994, researchers report, and the obesity epidemic is the most likely reason why. About one in 11 Americans now develops kidney stones, according to...

ODAC meeting to discuss RCC imagingFDA's Oncologic Drugs Advisory Committee (ODAC) will meet on July 25 to discuss the extent of useful clinical information provided by an imaging test for clear cell renal cell carcinoma (RCC) before surgery. FDA will also review the development strat...

CHMP recommends perampanel, aclidinium bromideEMA's CHMP issued several positive opinions on Friday, including one backing approval of Fycompa perampanel from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) to treat partial-onset seizures in epilepsy patients. The committee also supported approval of Br...

'American Idol' Winner Undergoes Surgeries During ContestBy Celebrity Diagnosis We all know that "American Idol" can be a grueling experience for its contestants. But imagine undergoing eight surgical procedures over the course of it... We were aware that Season 11 winner Philip Phillips had bee...

Cancer Imaging In Clear Cell Renal Carcinoma Gets ODAC Attention As Pipeline FillsFDA’s Oncologic Drugs Advisory Committee will examine the extent (if any) to which the pre-surgical identification of clear cell carcinoma of the kidney using an imaging test provides useful clinical information. ASCO abstracts show considerable re...

Pfizer says EU recommends approval of InlytaPfizer Inc. said Friday that European Union regulators are recommending approval for its kidney cancer drug Inlyta.A European Union advisory committee recommended that Inlyta be approved as a treatment for advanced renal cell carcinoma in patients w...

Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EUPfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of pri...

Obesity Ups Kidney Injury in Heart Surgery (CME/CE)(MedPage Today) -- Obese patients may be at risk for acute kidney injury after heart surgery, but therapies designed to reduce oxidative stress could potentially reduce that risk, researchers report.

'Negative' Finding Bolsters Case for Clinical Trials (CME/CE)SAN FRANCISCO (MedPage Today) -- A "completely negative” study of a possible preventive therapy for acute kidney injury after cardiac surgery reinforces the need for clinical research.

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinomaPfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adu...

Baxter's Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing DialysisPARIS, France (May 25, 2012) — Baxter International Inc. (NYSE: BAX) today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis (PD) regimen favorably impacted metabolic measure...

BPH Symptoms Can Be Improved with New Thermobalancing Therapy Without Potentially Harmful Drugs & Prostate Surgeries, Reveals Fine TreatmentThe improvement to BPH symptoms with the use of new Thermobalancing Therapy comes gradually; for instance, the urinary symptoms at first ease during the day and later in the night, Fine Treatment highlights. This therapy decreases the size of the enlarged prostate naturally without resorting to potentially harmful BPH drugs and prostate surgeries. London, UK (PRWEB) May 25, 2012 With the new Ther...

Zytoprotec Completes Phase I/II Trial of Novel DialysateZytoprotec, a company developing drugs based on active cytoprotection, announced the completion of a Phase I/II clinical trial with its lead product, PD-protec™. The product is developed to improve the treatment of patients with kidney failure.“T...

Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing DialysisBaxter International Inc. (NYSE: BAX) today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis (PD) regimen favorably impacted metabolic measures important for end-stage renal disease (ESRD) patients with diabetes, including blood glucose (sugar) control and selected lipids (fats and chol...

immatics Wins 2012 TiE50 AwardTUEBINGEN, Germany, May 25, 2012 /PRNewswire/ -- immatics chosen as a leading company in the life sciences category by the world's largest entrepreneurial network immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that it has been named a 2012 TiE50 winner. These prestigious awards re...

Percutaneous nephrolitholapaxy treats large renal stonesNEW YORK (Reuters Health) - Minimally invasive percutaneous nephrolitholapaxy (MIP), useful for fragmenting small renal stones, can also be used to treat stones larger than 20 mm in diameter, according to a group from Tuebingen, Germany.

Oxidative stress may put obese patients at increased risk of kidney damage after heart surgeryOxidative stress may put obese patients at increased risk of developing kidney damage after heart surgery, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

Study Validating miRview mets2 Published in The Oncologist PHILADELPHIA, PA and REHOVOT, ISRAEL -- (Marketwire) -- 05/25/12 -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced that data from studies of miRview® mets² in patients with Cancer of Unknown and Uncertain Primary ("CUP") were published online in The Oncologist in an article titled, "A second generation microR...

Folic Acid May Reduce Pediatric Kidney And Brain TumorsA new study in the current issue of Pediatrics reveals that folic acid fortification of foods could potentially reduce the number of incidences of Wilm's tumor, the most common type of kidney cancer, and primitive neuroectodermal tumors (PNET), a typ...

How Patients Use Facebook To Solicit Kidney DonationsLoyola University Medical Center researchers are reporting one of the first studies to examine how patients and families are soliciting living kidney donors on Facebook. Researchers examined 91 Facebook pages that were seeking kidney donations for pa...

Obesity Epidemic Likely Cause Of Huge Increase In Kidney StonesThe number of Americans suffering from kidney stones between 2007 and 2010 nearly doubled since 1994, according to a study by researchers at the University of California, Los Angeles (UCLA) and RAND. "While we expected the prevalence of kidney stones...

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer’s clinical data package for tafamidis meglumine. Tafamidis is a novel, investigational, oral therapy for the treatment of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) in...

UPMC Presbyterian Shadyside Hospital Will Participate in Aetna’s Institutes of Excellence™ Transplant NetworkAetna (NYSE: AET) announced today that UPMC Presbyterian Shadyside Hospital has been designated as a participating facility in Aetna’s Institutes of Excellence™ Transplant Network. The Institutes of Excellence (IOE) is Aetna’s participating network for transplants and transplant-related services. The IOE is comprised of hospitals that...

0 1 2 3 4 ›»

buy Renal market research data and corporate reports now Advertisement